吻合装置の世界市場（2024年～2031年）

吻合装置市場規模、シェア、動向分析レポート：製品別（使い捨て、再利用可能）、用途別（心臓血管外科、消化器外科、その他）、エンドユーザー別（病院、外来診療センター、クリニック）予測期間（2024-2031年）

吻合器市場は予測期間（2024-2031年）にCAGR 5.2％で成長すると予測されます。慢性疾患の有病率の増加と技術の進歩が吻合装置の需要を牽引しています。また、新興国市場でのヘルスケア支出の増加や医療インフラの改善も市場成長に寄与しています。

市場力学

慢性疾患の増加

慢性疾患の増加により、心臓病に対する冠動脈バイパス移植術（CABG）などの外科手術の際に吻合器具の使用が必要となっています。National Center for Chronic Disease Prevention and Health Promotionによると、2024年2月には、米国のかなりの数の個人、約1億2,900万人が、心臓病、がん、糖尿病、肥満、高血圧などの主要な慢性疾患に罹患しています。さらに、予防可能で治療可能な慢性疾患は、同国における死亡原因の上位10位中5位を占めると推定され、主要な死亡原因のひとつとなっています。このような有病率の増加傾向は過去20年間続いており、今後も続くと予測されています。個人的な影響に加え、慢性疾患や精神疾患の管理・治療が、米国における年間4兆1,000億ドルのヘルスケア支出の約90.0％を占めています。

外科手術の増加

外科手術の増加により、外科ハブへの需要が高まっています。保健社会福祉省によると、2022年8月、新たに50以上の外科ハブが追加され、吻合装置の需要が大幅に増加しました。政府はこのイニシアチブを支援するために15億ポンドの資金を割り当てており、今後3年間で約200万件のルーチン手術が追加されるとの予測が出ています。

市場セグメンテーション

• 製品は、再使用型と使い捨て型に区分されます。
• エンドユーザー別に見ると、市場は病院、外来医療センター、診療所に区分されます。
• 用途別では、市場は心臓血管外科、消化器外科、その他（血管処置）に区分されます。

心臓血管外科が最大セグメントとして台頭すると予測

同分野の成長を支える主な要因には、CABGや血管再建などの治療に対する需要があり、吻合器具の使用が求められています。世界心臓連盟によると、2023年、心血管疾患は世界的に大きな影響力を持ち、2021年には5億人以上が罹患し、2,050万人が死亡しています。これは世界の死亡者数の約3分の1を占めます。心血管医学の進歩により、早発心臓発作と脳卒中の最大80.0％を予防できる可能性が示されていますが、心血管健康の進歩は依然として高所得国に集中しているため、既存の健康格差に対処することが極めて重要です。

地域別展望

世界の吻合器市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋（インド、中国、日本、韓国、その他アジア太平洋地域）、世界のその他の地域（中東とアフリカ、中南米）を含む地域別にさらに細分化されています。

北米が主要市場シェアを占める

がん罹患率の上昇により、吻合装置は腫瘍切除や臓器摘出などの処置に不可欠となり、血液動脈や臓器の再接続が地域市場の需要を牽引しています。米国国立がん研究所によると、2024年5月、米国では新たに200万人のがん患者が発生し、61万1,720人が死亡すると予想されています。一般的ながんには、乳がん、前立腺がん、肺がん、結腸がん、直腸がん、皮膚がん、膀胱がん、腎臓がん、腎盂がん、非ホジキンリンパ腫、子宮内膜がん、膵臓がん、白血病、甲状腺がん、肝臓がんなどがあります。がんの罹患率は男女とも年間10万人当たり440.5人で、死亡率は男性の方が高いです。非ヒスパニック系黒人男性のがん死亡率が最も高いです。2022年1月現在、がん生存者は1,810万人で、2032年には2,250万人に増加すると予測されています。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主要市場動向
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• B. Braun Melsungen
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Intuitive Surgical Inc.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Medtronic Plc
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• 吻合装置の世界市場：製品別
  • 再利用可能
  • 使い捨て
• 吻合装置の世界市場：エンドユーザー別
  • 病院
  • 外来医療センターおよび診療所
• 吻合装置の世界市場：用途別
  • 心臓血管外科
  • 消化器外科
  • その他（血管処置）

第5章 地域別分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 企業プロファイル

• Artivion Inc.
• Baxter International Inc.（Synovis Micro Companies Alliance, Inc.）
• Becton, Dickinson and Company
• Boston Scientific Corp.
• Carponovum AB
• ETHICON, Inc.（Johnson & Johnson Services, Inc.）
• Getinge AB
• LivaNova Plc
• Medline Industries, LP
• Meril Lifesciences Pvt. Ltd.
• Mizuho Medical Co., Ltd（MIZUHO Corporation）
• Peters Surgical Solutions Ltd.
• Seger Surgical Solutions Ltd.
• Vascular Graft Solutions Ltd.

LIST OF TABLES

• 1. Global Anastomosis Devices Market Research And Analysis By Product, 2023-2031 ($ Million)
• 2. Global Reusable Anastomosis Devices Market Research And Analysis By Region, 2023-2031 ($ Million)
• 3. Global Disposable Anastomosis Devices Market Research And Analysis By Region, 2023-2031 ($ Million)
• 4. Global Anastomosis Devices Market Research And Analysis By End-User, 2023-2031 ($ Million)
• 5. Global Anastomosis Devices For Hospitals Market Research And Analysis By Region, 2023-2031 ($ Million)
• 6. Global Anastomosis Devices For Ambulatory Care Centers And Clinics Market Research And Analysis By Region, 2023-2031 ($ Million)
• 7. Global Anastomosis Devices Market Research And Analysis By Application, 2023-2031 ($ Million)
• 8. Global Anastomosis Devices For Cardiovascular Surgery Market Research And Analysis By Region, 2023-2031 ($ Million)
• 9. Global Anastomosis Devices For Gastrointestinal Surgery Market Research And Analysis By Region, 2023-2031 ($ Million)
• 10. Global Anastomosis Devices For Other Surgery Market Research And Analysis By Region, 2023-2031 ($ Million)
• 11. Global Anastomosis Devices Market Research And Analysis By Region, 2023-2031 ($ Million)
• 12. North American Anastomosis Devices Market Research And Analysis By Country, 2023-2031 ($ Million)
• 13. North American Anastomosis Devices Market Research And Analysis By Product, 2023-2031 ($ Million)
• 14. North American Anastomosis Devices Market Research And Analysis By End-User, 2023-2031 ($ Million)
• 15. North American Anastomosis Devices Market Research And Analysis By Application, 2023-2031 ($ Million)
• 16. North American Anastomosis Devices Market Research And Analysis By Product, 2023-2031 ($ Million)
• 17. European Anastomosis Devices Market Research And Analysis By Country, 2023-2031 ($ Million)
• 18. European Anastomosis Devices Market Research And Analysis By Product, 2023-2031 ($ Million)
• 19. European Anastomosis Devices Market Research And Analysis By End-User, 2023-2031 ($ Million)
• 20. European Anastomosis Devices Market Research And Analysis By Application, 2023-2031 ($ Million)
• 21. European Anastomosis Devices Market Research And Analysis By Product, 2023-2031 ($ Million)
• 22. Asia-Pacific Anastomosis Devices Market Research And Analysis By Country, 2023-2031 ($ Million)
• 23. Asia-Pacific Anastomosis Devices Market Research And Analysis By Product, 2023-2031 ($ Million)
• 24. Asia-Pacific Anastomosis Devices Market Research And Analysis By Application, 2023-2031 ($ Million)
• 25. Asia-Pacific Anastomosis Devices Market Research And Analysis By End-User, 2023-2031 ($ Million)
• 26. Asia-Pacific Anastomosis Devices Market Research And Analysis By Product, 2023-2031 ($ Million)
• 27. Rest Of The World Anastomosis Devices Market Research And Analysis By Region, 2023-2031 ($ Million)
• 28. Rest Of The World Anastomosis Devices Market Research And Analysis By Product, 2023-2031 ($ Million)
• 29. Rest Of The World Anastomosis Devices Market Research And Analysis By End-User, 2023-2031 ($ Million)
• 30. Rest Of The World Anastomosis Devices Market Research And Analysis By Application, 2023-2031 ($ Million)

LIST OF FIGURES

• 1. Global Anastomosis Devices Market Share By Product, 2023 Vs 2031 (%)
• 2. Global Disposable Anastomosis Devices Market Share By Region, 2023 Vs 2031 (%)
• 3. Global Reusable Anastomosis Devices Market Share By Region, 2023 Vs 2031 (%)
• 4. Global Anastomosis Devices Market Share By End-User, 2023 Vs 2031 (%)
• 5. Global Anastomosis Devices Market For Hospital Market Share By Region, 2023 Vs 2031 (%)
• 6. Global Anastomosis Devices Market For Ambulatory Care Centers And Clinics Market Share By Region, 2023 Vs 2031 (%)
• 7. Global Anastomosis Devices Market Share By Application, 2023 Vs 2031 (%)
• 8. Global Anastomosis Devices For Cardiovascular Surgery Market Share By Region, 2023 Vs 2031 (%)
• 9. Global Anastomosis Devices For Gastrointestinal Surgery Market Share By Region, 2023 Vs 2031 (%)
• 10. Global Anastomosis Devices For Other Surgery Market Share By Region, 2023 Vs 2031 (%)
• 11. Global Anastomosis Devices Market Share By Region, 2023 Vs 2031 (%)
• 12. US Anastomosis Devices Market Size, 2023-2031 ($ Million)
• 13. Canada Anastomosis Devices Market Size, 2023-2031 ($ Million)
• 14. UK Anastomosis Devices Market Size, 2023-2031 ($ Million)
• 15. France Anastomosis Devices Market Size, 2023-2031 ($ Million)
• 16. Germany Anastomosis Devices Market Size, 2023-2031 ($ Million)
• 17. Italy Anastomosis Devices Market Size, 2023-2031 ($ Million)
• 18. Spain Anastomosis Devices Market Size, 2023-2031 ($ Million)
• 19. Rest Of Europe Anastomosis Devices Market Size, 2023-2031 ($ Million)
• 20. India Anastomosis Devices Market Size, 2023-2031 ($ Million)
• 21. China Anastomosis Devices Market Size, 2023-2031 ($ Million)
• 22. Japan Anastomosis Devices Market Size, 2023-2031 ($ Million)
• 23. South Korea Anastomosis Devices Market Size, 2023-2031 ($ Million)
• 24. Rest Of Asia-Pacific Anastomosis Devices Market Size, 2023-2031 ($ Million)
• 25. Latin America Anastomosis Devices Market Size, 2023-2031 ($ Million)
• 26. Middle East And Africa Anastomosis Devices Market Size, 2023-2031 ($ Million)

Anastomosis Devices Market Size, Share & Trends Analysis Report by Product (Disposable, and Reusable), by Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Others), by End-User (Hospitals, Ambulatory Care Centers, and Clinics) Forecast Period (2024-2031)

Anastomosis devices market is anticipated to grow at a CAGR of 5.2% during the forecast period (2024-2031). The increasing prevalence of chronic diseases and technological advancements drives the demand for anastomosis devices. Additionally, the rising healthcare expenditure in developing countries and improved medical infrastructure contribute to market growth.

Market Dynamics

Rising Incidence of Chronic Diseases

The increasing occurrence of chronic diseases necessitates the use of anastomosis devices during surgical procedures, such as coronary artery bypass grafting (CABG) for heart disease. According to the National Center for Chronic Disease Prevention and Health Promotion, in February 2024, a significant number of individuals in the US, approximately 129 million, are affected by major chronic diseases, such as heart disease, cancer, diabetes, obesity, and hypertension. Moreover, preventable and treatable chronic diseases are among the leading causes of mortalities in the country, contributing to an estimated five out of the top ten causes. This trend of increasing prevalence has persisted over the past two decades and is projected to continue, with a growing proportion of Americans experiencing multiple chronic conditions. In addition to the personal influence, the management and treatment of chronic diseases and mental health conditions account for around 90.0% of the annual $4.1 trillion expenditure on healthcare in the US.

Increased Surgical Procedures

Increased surgical procedures have created a demand for surgical hubs. According to the Department of Health and Social Care, in August 2022, the addition of over 50 new surgical hubs significantly increased demand for anastomosis devices. The government has allocated £1.5 billion in funding to support this initiative, with projections indicating that nearly 2 million additional routine operations will be performed over the next three years.

Market Segmentation

• Based on product, the market is segmented into reusable, and disposable.
• Based on end-users, the market is segmented into hospitals, ambulatory care centers, and clinics.
• Based on application, the market is segmented into cardiovascular surgery, gastrointestinal surgery, and others (vascular procedures).

Cardiovascular Surgery is Projected to Emerge as the Largest Segment

The primary factor supporting the segment's growth includes the demand for treatments such as CABG and vascular reconstructions, that demand for the use of anastomosis devices. According to the World Heart Federation, in 2023, cardiovascular diseases have a significant influence globally, with over half a billion individuals affected and 20.5 million mortalities recorded in 2021. This accounts for approximately one-third of all global mortalities. While advances in cardiovascular medicine have shown potential in preventing up to 80.0% of premature heart attacks and strokes, it is crucial to address the existing health inequity, as progress in cardiovascular health remains concentrated in high-income countries.

Regional Outlook

The global anastomosis devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

North America Holds Major Market Share

The rising rate of cancer renders anastomosis devices essential for procedures such as tumor excision and organ removal to reconnect blood arteries or organs driving the demand for regional markets. According to the National Cancer Institute, in May 2024, the US is expected to see 2 million new cancer cases and 611,720 mortalities. Common cancers include breast, prostate, lung, colon, rectum, skin, bladder, kidney, renal pelvis, non-Hodgkin lymphoma, endometrial, pancreatic, leukemia, thyroid, and liver cancer. The cancer incidence is 440.5 per 100,000 men and women per year, with a higher mortality rate among men. Non-Hispanic Black men have the highest cancer mortality rate. As of January 2022, there were 18.1 million cancer survivors, with a projected increase to 22.5 million by 2032.

Market Players Outlook

The major companies serving the global anastomosis devices market include B. Braun Melsungen, Intuitive Surgical Inc., Baxter International Inc. (Synovis Micro Companies Alliance, Inc.), Medtronic Plc, and Johnson & Johnson (Ethicon US, LLC) among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in June 2022, Ethicon, part of Johnson & Johnson MedTech, launched the ECHELON 3000 Stapler in the US, a digitally enabled device that offers surgeons one-handed powered articulation, improved access, control, and real-time feedback for critical adjustments.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Market Trends
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. B. Braun Melsungen
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Intuitive Surgical Inc.
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Medtronic Plc
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Anastomosis Devices Market by Product
  • 4.1.1. Reusable
  • 4.1.2. Disposable
• 4.2. Global Anastomosis Devices Market by End-User
  • 4.2.1. Hospitals
  • 4.2.2. Ambulatory Care Centers and Clinics
• 4.3. Global Anastomosis Devices Market by Application
  • 4.3.1. Cardiovascular Surgery
  • 4.3.2. Gastrointestinal Surgery
  • 4.3.3. Others (Vascular Procedures)

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World
  • 5.4.1. Latin America
  • 5.4.2. Middle East & Africa

6. Company Profiles

• 6.1. Artivion Inc.
• 6.2. Baxter International Inc. (Synovis Micro Companies Alliance, Inc.)
• 6.3. Becton, Dickinson and Company
• 6.4. Boston Scientific Corp.
• 6.5. Carponovum AB
• 6.6. ETHICON, Inc. (Johnson & Johnson Services, Inc.)
• 6.7. Getinge AB
• 6.8. LivaNova Plc
• 6.9. Medline Industries, LP
• 6.10. Meril Lifesciences Pvt. Ltd.
• 6.11. Mizuho Medical Co., Ltd (MIZUHO Corporation)
• 6.12. Peters Surgical Solutions Ltd.
• 6.13. Seger Surgical Solutions Ltd.
• 6.14. Vascular Graft Solutions Ltd.